Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma

Description

Prospective, multicenter, single-arm study of the iStent infinite in adult pseudophakic or phakic subjects with mild to moderate primary open angle glaucoma who have not failed conventional medical and surgical treatment

Conditions

Glaucoma

Talk to us

Study Overview

On this page

Study Details

Study overview

Prospective, multicenter, single-arm study of the iStent infinite in adult pseudophakic or phakic subjects with mild to moderate primary open angle glaucoma who have not failed conventional medical and surgical treatment

A Prospective, Multicenter Study of the Glaukos® iStent Infinite Trabecular Micro-Bypass System Model iS3 in Subjects With Mild to Moderate Primary Open-angle Glaucoma

Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma

Condition
Glaucoma
Intervention / Treatment

-

Contacts and Locations

Cincinnati

Glaukos Investigator Site, Cincinnati, Ohio, United States, 45242

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Diagnosis of primary open-angle glaucoma
  • * Phakic or pseudophakic
  • * Age 35 years or older
  • * Traumatic, uveitic, neovascular, angle-closure glaucoma or
  • * glaucoma associated with vascular disorders
  • * Active corneal inflammation or edema
  • * Retinal disorders not associated with glaucoma

Ages Eligible for Study

35 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Glaukos Corporation,

Study Record Dates

2027-08